InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Carole Ho, Chief Medical Officer, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 31 open-market SEC Form 4 transactions: 0 purchases worth $0 and 31 sales worth $2.7M, reported from Aug 19, 21 to Aug 13, 25. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 13, 25 | DNLIDenali Therapeutics Inc. | SELL | 806 | $14.64 | $12K |
| Aug 12, 25 | DNLIDenali Therapeutics Inc. | SELL | 2.9K | $13.58 | $40K |
| Jan 7, 25 | DNLIDenali Therapeutics Inc. | SELL | 2.9K | $20.81 | $60K |
| Jan 6, 25 | DNLIDenali Therapeutics Inc. | SELL | 12.3K | $20.22 | $248K |
| Aug 21, 24 | DNLIDenali Therapeutics Inc. | SELL | 14.1K | $24.96 | $344K |
| Aug 20, 24 | DNLIDenali Therapeutics Inc. | SELL | 2.5K | $23.79 | $58K |
| Aug 13, 24 | DNLIDenali Therapeutics Inc. | SELL | 2.3K | $22.89 | $53K |
| Feb 14, 24 | DNLIDenali Therapeutics Inc. | SELL | 1.4K | $17.79 | $25K |
| Feb 13, 24 | DNLIDenali Therapeutics Inc. | SELL | 2.8K | $17.29 | $48K |
| Jan 10, 24 | DNLIDenali Therapeutics Inc. | SELL | 4.7K | $19.02 | $89K |
| Jan 5, 24 | DNLIDenali Therapeutics Inc. | SELL | 10.0K | $19.43 | $194K |
| Aug 23, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.5K | $23.22 | $59K |
| Aug 21, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.5K | $22.60 | $56K |
| Aug 14, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.8K | $23.79 | $66K |
| Aug 10, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.9K | $24.15 | $69K |
| Feb 15, 23 | DNLIDenali Therapeutics Inc. | SELL | 1.5K | $29.40 | $43K |
| Feb 13, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.5K | $30.10 | $77K |
| Feb 10, 23 | DNLIDenali Therapeutics Inc. | SELL | 818 | $29.80 | $24K |
| Feb 8, 23 | DNLIDenali Therapeutics Inc. | SELL | 1.5K | $30.88 | $47K |
| Jan 9, 23 | DNLIDenali Therapeutics Inc. | SELL | 1.5K | $28.48 | $42K |
| Jan 6, 23 | DNLIDenali Therapeutics Inc. | SELL | 1.5K | $28.67 | $42K |
| Jan 5, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.6K | $28.44 | $75K |
| Jan 4, 23 | DNLIDenali Therapeutics Inc. | SELL | 2.9K | $28.69 | $84K |
| Aug 23, 22 | DNLIDenali Therapeutics Inc. | SELL | 2.4K | $31.98 | $78K |
| Aug 19, 22 | DNLIDenali Therapeutics Inc. | SELL | 2.6K | $33.22 | $86K |
| Feb 11, 22 | DNLIDenali Therapeutics Inc. | SELL | 2.9K | $34.71 | $101K |
| Feb 9, 22 | DNLIDenali Therapeutics Inc. | SELL | 1.4K | $37.10 | $53K |
| Jan 5, 22 | DNLIDenali Therapeutics Inc. | SELL | 2.8K | $44.78 | $127K |
| Dec 6, 21 | DNLIDenali Therapeutics Inc. | SELL | 1.5K | $42.52 | $63K |
| Aug 23, 21 | DNLIDenali Therapeutics Inc. | SELL | 6.1K | $48.91 | $300K |
| Aug 19, 21 | DNLIDenali Therapeutics Inc. | SELL | 1.4K | $49.91 | $69K |